| Product Code: ETC13266871 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Insomnia Market was valued at USD 5.6 Billion in 2024 and is expected to reach USD 8.9 Billion by 2031, growing at a compound annual growth rate of 6.50% during the forecast period (2025-2031).
The Global Insomnia Market is experiencing steady growth due to the increasing prevalence of insomnia worldwide. Factors such as high-stress levels, changing lifestyles, and rising geriatric population contribute to the rising demand for insomnia treatment options. The market is characterized by a variety of pharmaceutical and non-pharmaceutical treatment options, including prescription medications, over-the-counter drugs, cognitive behavioral therapy, and relaxation techniques. Key players in the market focus on developing innovative therapies and products to address the unmet needs of patients suffering from insomnia. Geographically, North America dominates the market due to high healthcare expenditure and awareness about sleep disorders. However, the Asia-Pacific region is expected to witness significant growth driven by improving healthcare infrastructure and rising disposable income levels. The Global Insomnia Market is poised for further expansion with ongoing research and development efforts to introduce advanced treatment modalities.
The Global Insomnia Market is witnessing a growing trend towards the adoption of non-pharmacological therapies such as cognitive behavioral therapy for insomnia (CBT-I) due to concerns over the long-term use of medication. The market is also experiencing a rise in the development of innovative digital health solutions and wearable devices aimed at improving sleep quality and tracking patterns. Additionally, there is an increasing focus on personalized medicine approaches to address individual factors contributing to insomnia. Opportunities lie in the expansion of telemedicine services for remote diagnosis and treatment, as well as collaborations between pharmaceutical companies and technology firms to create comprehensive insomnia management platforms. The market is expected to continue growing as awareness about the impact of insomnia on overall health and well-being increases globally.
The Global Insomnia Market faces several challenges, including limited awareness about the condition leading to underdiagnosis, high costs associated with diagnosis and treatment, lack of effective and universally accepted treatment options, and the potential for side effects from commonly prescribed medications. Additionally, there is a growing concern regarding the overuse of prescription sleep aids and the rise of alternative therapies that lack scientific validation. The market is also impacted by regulatory hurdles in drug approval processes and the need for more personalized treatment approaches to address the diverse underlying causes of insomnia in different patient populations. Overall, overcoming these challenges requires collaborative efforts from healthcare providers, pharmaceutical companies, regulators, and researchers to improve diagnosis rates, develop innovative therapies, and ensure better access to effective treatments for individuals suffering from insomnia.
The Global Insomnia Market is primarily driven by factors such as increasing prevalence of insomnia due to stressful lifestyles, rising geriatric population, growing awareness about mental health disorders, and the availability of advanced treatment options. Additionally, the adoption of sedentary lifestyles, changing work patterns, and the high prevalence of comorbid conditions such as depression and anxiety are also contributing to the growth of the insomnia market. Technological advancements in diagnostic tools and treatment modalities, along with the increasing healthcare expenditure and investments in research and development activities, are further fueling the market expansion. Moreover, the expansion of telemedicine services and the integration of digital health solutions for insomnia management are expected to drive the market in the coming years.
Government policies related to the Global Insomnia Market vary across countries but generally focus on the regulation of pharmaceuticals, healthcare services, and research funding. Governments often work to ensure the safety and efficacy of insomnia treatments through agencies like the FDA in the United States or the EMA in Europe, which oversee drug approval processes. Additionally, policies may aim to increase access to mental health services, promote public awareness campaigns about insomnia, and support research initiatives to develop new treatment options. Some governments also implement policies to regulate advertising of sleep aids and promote best practices in sleep medicine. Overall, government policies in the Global Insomnia Market are geared towards improving patient outcomes, ensuring quality care, and addressing the growing prevalence of sleep disorders worldwide.
The Global Insomnia Market is expected to see steady growth in the coming years due to factors such as a rising prevalence of insomnia worldwide, increasing awareness about the condition, and a growing aging population. Technological advancements in the healthcare sector, such as the development of innovative treatment options and wearable devices for monitoring sleep patterns, are also likely to drive market growth. Additionally, the increasing adoption of telemedicine and online therapy platforms for insomnia treatment is expected to further boost market expansion. However, challenges such as the high cost of treatment and potential side effects of medications may hinder market growth to some extent. Overall, the Global Insomnia Market is projected to experience continued growth in the foreseeable future.
In the global insomnia market, Asia is expected to witness significant growth due to the increasing awareness about sleep disorders and rising healthcare expenditure. North America leads the market with a high prevalence of insomnia cases and a strong focus on research and development for innovative treatment options. Europe follows closely behind with a growing aging population and increasing adoption of advanced therapies. The Middle East and Africa region is anticipated to witness steady growth as healthcare infrastructure improves and awareness about insomnia rises. Latin America is also showing promising growth potential driven by improving access to healthcare services and a rising prevalence of stress-related sleep disorders. Overall, the global insomnia market is characterized by increasing demand for effective treatment options and a growing emphasis on holistic approaches to managing sleep disorders across different regions.
Global Insomnia Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Insomnia Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Insomnia Market Revenues & Volume, 2021 & 2031F |
3.3 Global Insomnia Market - Industry Life Cycle |
3.4 Global Insomnia Market - Porter's Five Forces |
3.5 Global Insomnia Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Insomnia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Global Insomnia Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Global Insomnia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Insomnia Market Trends |
6 Global Insomnia Market, 2021 - 2031 |
6.1 Global Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Insomnia Market, Revenues & Volume, By Benzodiazepines, 2021 - 2031 |
6.1.3 Global Insomnia Market, Revenues & Volume, By Nonbenzodiazepines, 2021 - 2031 |
6.1.4 Global Insomnia Market, Revenues & Volume, By Antidepressants, 2021 - 2031 |
6.1.5 Global Insomnia Market, Revenues & Volume, By Orexin Antagonist, 2021 - 2031 |
6.1.6 Global Insomnia Market, Revenues & Volume, By Melatonin Antagonist, 2021 - 2031 |
6.1.7 Global Insomnia Market, Revenues & Volume, By Devices, 2021 - 2031 |
6.1.8 Global Insomnia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Insomnia Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.2.3 Global Insomnia Market, Revenues & Volume, By Retail Pharmacies and Drug Stores, 2021 - 2031 |
6.2.4 Global Insomnia Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Insomnia Market, Overview & Analysis |
7.1 North America Insomnia Market Revenues & Volume, 2021 - 2031 |
7.2 North America Insomnia Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Insomnia Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Insomnia Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Insomnia Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
8 Latin America (LATAM) Insomnia Market, Overview & Analysis |
8.1 Latin America (LATAM) Insomnia Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Insomnia Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Insomnia Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Insomnia Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Insomnia Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Insomnia Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.4 Latin America (LATAM) Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
9 Asia Insomnia Market, Overview & Analysis |
9.1 Asia Insomnia Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Insomnia Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Insomnia Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Insomnia Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Insomnia Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Insomnia Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.4 Asia Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
10 Africa Insomnia Market, Overview & Analysis |
10.1 Africa Insomnia Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Insomnia Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Insomnia Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Insomnia Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Insomnia Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Insomnia Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.4 Africa Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
11 Europe Insomnia Market, Overview & Analysis |
11.1 Europe Insomnia Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Insomnia Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Insomnia Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Insomnia Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Insomnia Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Insomnia Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.4 Europe Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
12 Middle East Insomnia Market, Overview & Analysis |
12.1 Middle East Insomnia Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Insomnia Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Insomnia Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Insomnia Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Insomnia Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Insomnia Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.4 Middle East Insomnia Market, Revenues & Volume, By Sales Channel, 2021 - 2031 |
13 Global Insomnia Market Key Performance Indicators |
14 Global Insomnia Market - Export/Import By Countries Assessment |
15 Global Insomnia Market - Opportunity Assessment |
15.1 Global Insomnia Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Insomnia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.3 Global Insomnia Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
16 Global Insomnia Market - Competitive Landscape |
16.1 Global Insomnia Market Revenue Share, By Companies, 2024 |
16.2 Global Insomnia Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |